Monte Rosa Therapeutics Inc

The current institutional shareholding score of Monte Rosa Therapeutics Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 85.28%, representing a quarter-over-quarter decrease of 12.06%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.45% of shares outstanding, with 0.29% increase in holdings.